UNSPSC 51131624: Dabigatran etexilate mesilate

This classification denotes an anticoagulant agent, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier SC7NUW5IIT. The European Medicines Agency schedules Dabigatran etexilate mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27581. Dabigatran etexilate mesilate generally arises in the molecular formula C34H41N7O5.CH4O3S. The term 'dabigatran etexilate mesilate' is a European Medicines Agency European Public Assessment Report System designation.

SMILES: CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N.

UNSPSC 51131624 Dabigatran etexilate mesilate is a Commodity code representing a specific anticoagulant pharmaceutical product used in clinical and public health settings. State and local government procurement under this code covers pharmaceutical supply contracts for healthcare delivery, emergency medical services, and institutional medical facilities operated or funded by public entities. The issuing bodies soliciting pharmaceutical supplies at this specificity level span state health departments, county public health agencies, municipal hospitals and urgent-care facilities, correctional systems, and regional medical authorities.

The recent opportunities block contains one solicitation posting, though it is mismatched to the code's pharmaceutical scope: Sourcewell, a Minnesota local government cooperative, issued RFP #061626 on May 12, 2026 (due June 16, 2026) for law enforcement equipment on behalf of Franklin County, Grant County, Grays Harbor County, Chelan County, Yakima County, and other jurisdictions across the United States and Canada. This procurement is unrelated to dabigatran etexilate mesilate or pharmaceutical supply. The code shows little relevant recent activity in the available state and local opportunity record.